Trial
NCT00314327
Optimizing Response in Psychosis Study
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
The Zucker Hillside Hospital; National Alliance for Research on Schizophrenia and Depression
Condition
Schizophrenia
Intervention
long-acting injectable risperidone
Why stopped
Recruitment for the study was limited.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-16